Ipsen SA and RNA splicing modifier specialist Skyhawk Therapeutics Inc have entered a US$1.8bn licencing...
Up To Date
Latest News
French drug maker Seabelife SAS will use a €1.5m price money to develop a new dual-acting necroptosis blocker...
Waste based biosurfactants producer Amphistar BV has closed a €6m funding round led by the European Circular...
Vaccine maker Sumagen Co. Ltd has launched a cGMP manufacturing partnership with French Naobios SAS for...
Finnish Solar Foods Oy has started microbial production of its protein powder Solein in Factory 01, Solar...
German AdrenoMed AG has got FDA Fast Track designation for its targeted septic shock medicine enibarcimab that...